The NIH Office of Research on Women’s Health presents:
Beyond the Fig Leaf: The Science of Sex and Gender Differences
October 9, 2012, 3:00 – 5:00 pm

For those are not able to attend in person can view the program by videocast at’

Symposium Overview: Personalized medicine provides the promise of improved healthcare informed by research on the factors that makes each human unique. Sex and gender are basic variables used to categorize differences and similarities; these variables influence health, including the experience, treatment, and outcomes of disease. The integration of sex and gender in the design and analysis of basic and clinical research studies can enhance the rigor of investigative approaches, improve the quality of the science, and expand the applicability of the results, supporting a personalized medicine approach that can transform public health. This session will cover aspects of sex and gender factors in health and disease, from the development of biomedical devices and therapeutics to the personalization of treatment of cardiovascular disease. Discussion of the latest scientific advances in sex differences research and enhancements in study design to detect sex and gender differences will engage and inform the NIH scientific community.

Session Talks:

  • Sex and Gender Differences in Cardiovascular Disease and Healthcare Delivery. Dr. Nakela Cook, Medical Officer in the Clinical Applications and Prevention Branch in the Division of Cardiovascular Sciences, NHLBI
  • Sex and Gender Considerations in Devices and Therapeutics. Dr. Belinda Seto, Deputy Director of the National Institute of Biomedical Imaging and Bioengineering, NIBIB
  • Gender in Genetic and Genomic Research. Dr. Susan Taymans, Director for the Reproductive Genetics and Epigenetics, NICHD
  • Sex and Gender Differences in Pain. Dr. Cora Lee Wetherington, Women and Sex/Gender Differences Research Coordinator and Health Scientist Administrator, NIDA
  • A Few Tricks and Traps when Designing Studies and Evaluating Sex and Gender Differences. Dr. Laura Johnson, Biostatistician, Office of Clinical and Regulatory Affairs, NCCAM
  • Obesity-related hormones and endometrial cancer risk among postmenopausal women: The BFIT cohort Dr. Cher Dallal, FARE Award winner and Cancer Prevention Fellow, NCI


Return to SGHC Homepage